-+ 0.00%
-+ 0.00%
-+ 0.00%

Bayer: The phase III DASL-HICAP trial reached the primary end of metastasis-free survival.

Zhitongcaijing·10/24/2026 06:33:00
Listen to the news
Bayer: The phase III DASL-HICAP trial reached the primary end of metastasis-free survival.